USANA HEALTH SCIENCES, INC. Operating Income
USANA HEALTH SCIENCES, INC. (USNA) reported Operating Income of -$20.00 million for the 3-month period ending 2026-07-04, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-13
- USANA HEALTH SCIENCES, INC. operating income (loss) for the quarter ending 2026-07-04 was -$20.00M, a 219.61% decline year-over-year.
- USANA HEALTH SCIENCES, INC. operating income (loss) for the quarter ending 2026-04-04 was $13.87M, a 11.47% decline year-over-year.
- USANA HEALTH SCIENCES, INC. operating income (loss) for the quarter ending 2026-01-03 was $3.82M, a 53.48% decline year-over-year.
- USANA HEALTH SCIENCES, INC. operating income (loss) for the quarter ending 2025-09-27 was $1.22M, a 92.15% decline year-over-year.
- USANA HEALTH SCIENCES, INC. operating income (loss) for fiscal 2026 was $37.43M, a 43.56% decline from fiscal 2024.
- USANA HEALTH SCIENCES, INC. operating income (loss) for fiscal 2024 was $66.32M, a 28.74% decline from fiscal 2023.
- USANA HEALTH SCIENCES, INC. operating income (loss) for fiscal 2023 was $93.07M, a 13.51% decline from fiscal 2022.
- USANA HEALTH SCIENCES, INC. operating income (loss) for fiscal 2022 was $107.61M, a 36.77% decline from fiscal 2022.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-07-04 | -$20.00M 10-Q · filed 2026-08-13 | -$6.12M 10-Q · filed 2026-08-13 | -$2.30M derived: sum of 3 quarters · filed 2026-08-13 | -$1.08M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-04-04 | $13.87M 10-Q · filed 2026-05-12 | $17.69M derived: sum of 2 quarters · filed 2026-05-12 | $18.92M derived: sum of 3 quarters · filed 2026-05-12 | $35.63M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-01-03 | $3.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $5.04M derived: sum of 2 quarters · filed 2026-03-16 | $21.76M derived: sum of 3 quarters · filed 2026-08-13 | $37.43M 10-K · filed 2026-03-16 |
| 2025-09-27 | $1.22M 10-Q · filed 2025-11-05 | $17.94M derived: sum of 2 quarters · filed 2026-08-13 | $33.61M 10-Q · filed 2025-11-05 | $41.82M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-28 | $16.72M 10-Q · filed 2026-08-13 | $32.39M 10-Q · filed 2026-08-13 | $40.60M derived: sum of 3 quarters · filed 2026-08-13 | $56.20M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-29 | $15.67M 10-Q · filed 2026-05-12 | $23.88M derived: sum of 2 quarters · filed 2026-05-12 | $39.48M derived: sum of 3 quarters · filed 2026-05-12 | $57.32M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-28 | $8.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $23.81M derived: sum of 2 quarters · filed 2026-03-16 | $41.65M derived: sum of 3 quarters · filed 2026-03-16 | $66.32M 10-K · filed 2026-03-16 |
| 2024-09-28 | $15.60M 10-Q · filed 2025-11-05 | $33.44M derived: sum of 2 quarters · filed 2025-11-05 | $58.11M 10-Q · filed 2025-11-05 | $82.33M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-29 | $17.84M 10-Q · filed 2025-08-05 | $42.51M 10-Q · filed 2025-08-05 | $66.73M derived: sum of 3 quarters · filed 2026-03-16 | $84.34M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-30 | $24.67M 10-Q · filed 2025-05-06 | $48.89M derived: sum of 2 quarters · filed 2026-03-16 | $66.50M derived: sum of 3 quarters · filed 2026-03-16 | $90.90M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-30 | $24.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $41.83M derived: sum of 2 quarters · filed 2026-03-16 | $66.23M derived: sum of 3 quarters · filed 2026-03-16 | $93.07M 10-K · filed 2026-03-16 |
| 2023-09-30 | $17.61M 10-Q · filed 2024-11-05 | $42.01M derived: sum of 2 quarters · filed 2024-11-05 | $68.85M 10-Q · filed 2024-11-05 | $91.40M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-07-01 | $24.40M 10-Q · filed 2024-08-06 | $51.24M 10-Q · filed 2024-08-06 | $73.80M derived: sum of 3 quarters · filed 2025-03-12 | $96.43M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-04-01 | $26.84M 10-Q · filed 2024-05-07 | $49.40M derived: sum of 2 quarters · filed 2025-03-12 | $72.03M derived: sum of 3 quarters · filed 2025-03-12 | $101.39M derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | $22.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $45.18M derived: sum of 2 quarters · filed 2025-03-12 | $74.55M derived: sum of 3 quarters · filed 2025-03-12 | $107.61M 10-K · filed 2025-03-12 |
| 2022-10-01 | $22.63M 10-Q · filed 2023-11-07 | $52.00M derived: sum of 2 quarters · filed 2023-11-07 | $85.06M 10-Q · filed 2023-11-07 | $116.57M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-02 | $29.37M 10-Q · filed 2023-08-08 | $62.43M 10-Q · filed 2023-08-08 | $93.94M derived: sum of 3 quarters · filed 2024-02-27 | $134.71M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-02 | $33.07M 10-Q · filed 2023-05-09 | $64.57M derived: sum of 2 quarters · filed 2024-02-27 | $105.34M derived: sum of 3 quarters · filed 2024-02-27 | $159.06M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-01-01 | $31.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $72.28M derived: sum of 2 quarters · filed 2024-02-27 | $126.00M derived: sum of 3 quarters · filed 2024-02-27 | $170.19M 10-K · filed 2024-02-27 |
| 2021-10-02 | $40.77M 10-Q · filed 2022-11-08 | $94.49M derived: sum of 2 quarters · filed 2022-11-08 | $138.69M 10-Q · filed 2022-11-08 | $191.22M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-07-03 | $53.72M 10-Q · filed 2022-08-09 | $97.92M 10-Q · filed 2022-08-09 | $150.46M derived: sum of 3 quarters · filed 2023-02-28 | $195.81M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-04-03 | $44.20M 10-Q · filed 2022-05-11 | $96.73M derived: sum of 2 quarters · filed 2023-02-28 | $142.09M derived: sum of 3 quarters · filed 2023-02-28 | $181.68M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-01-02 | $52.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $97.89M derived: sum of 2 quarters · filed 2023-02-28 | $137.48M derived: sum of 3 quarters · filed 2023-02-28 | $176.49M 10-K · filed 2023-02-28 |
| 2020-09-26 | $45.35M 10-Q · filed 2021-11-10 | $84.94M derived: sum of 2 quarters · filed 2021-11-10 | $123.95M 10-Q · filed 2021-11-10 | $168.52M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-27 | $39.59M 10-Q · filed 2021-08-11 | $78.60M 10-Q · filed 2021-08-11 | $123.17M derived: sum of 3 quarters · filed 2022-03-01 | $158.63M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-28 | $39.01M 10-Q · filed 2021-05-11 | $83.58M derived: sum of 2 quarters · filed 2022-03-01 | $119.04M derived: sum of 3 quarters · filed 2022-03-01 | $150.20M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-28 | $44.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $80.03M derived: sum of 2 quarters · filed 2022-03-01 | $111.19M derived: sum of 3 quarters · filed 2022-03-01 | $146.19M 10-K · filed 2022-03-01 |
| 2019-09-28 | $35.46M 10-Q · filed 2020-11-03 | $66.61M derived: sum of 2 quarters · filed 2020-11-03 | $101.62M 10-Q · filed 2020-11-03 | $150.19M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-29 | $31.16M 10-Q · filed 2020-08-04 | $66.16M 10-Q · filed 2020-08-04 | $114.73M derived: sum of 3 quarters · filed 2021-03-02 | $160.24M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-30 | $35.00M 10-Q · filed 2020-05-05 | $83.57M derived: sum of 2 quarters · filed 2021-03-02 | $129.09M derived: sum of 3 quarters · filed 2021-03-02 | $180.23M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-29 | $48.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $94.08M derived: sum of 2 quarters · filed 2021-03-02 | $145.22M derived: sum of 3 quarters · filed 2021-03-02 | $188.35M 10-K · filed 2021-03-02 |
| 2018-09-29 | $45.51M 10-Q · filed 2019-11-05 | $96.66M derived: sum of 2 quarters · filed 2019-11-05 | $139.78M 10-Q · filed 2019-11-05 | $175.68M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $51.14M 10-Q · filed 2019-08-06 | $94.27M 10-Q · filed 2019-08-06 | $130.16M derived: sum of 3 quarters · filed 2020-02-25 | $161.52M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $43.13M 10-Q · filed 2019-05-07 | $79.02M derived: sum of 2 quarters · filed 2020-02-25 | $110.38M derived: sum of 3 quarters · filed 2020-02-25 | $142.75M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-30 | $35.89M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $67.25M derived: sum of 2 quarters · filed 2020-02-25 | $99.62M derived: sum of 3 quarters · filed 2020-02-25 | $132.50M 10-K · filed 2020-02-25 |
| 2017-09-30 | $31.36M 10-Q · filed 2018-11-07 | $63.73M derived: sum of 2 quarters · filed 2018-11-07 | $96.61M 10-Q · filed 2018-11-07 | $128.45M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-07-01 | $32.37M 10-Q · filed 2018-08-08 | $65.25M 10-Q · filed 2018-08-08 | $97.09M derived: sum of 3 quarters · filed 2019-02-26 | $132.92M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-04-01 | $32.89M 10-Q · filed 2018-05-09 | $64.72M derived: sum of 2 quarters · filed 2019-02-26 | $100.56M derived: sum of 3 quarters · filed 2019-02-26 | $138.00M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $31.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $67.67M derived: sum of 2 quarters · filed 2019-02-26 | $105.12M derived: sum of 3 quarters · filed 2019-02-26 | $138.62M 10-K · filed 2019-02-26 |
| 2016-10-01 | $35.83M 10-Q · filed 2017-11-08 | $73.28M derived: sum of 2 quarters · filed 2017-11-08 | $106.79M 10-Q · filed 2017-11-08 | $141.92M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-07-02 | $37.45M 10-Q · filed 2017-08-09 | $70.95M 10-Q · filed 2017-08-09 | $106.09M derived: sum of 3 quarters · filed 2018-02-28 | $144.06M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-04-02 | $33.50M 10-Q · filed 2017-05-10 | $68.64M derived: sum of 2 quarters · filed 2018-02-28 | $106.61M derived: sum of 3 quarters · filed 2018-02-28 | $145.38M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-01-02 | $35.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $73.10M derived: sum of 2 quarters · filed 2018-02-28 | $111.88M derived: sum of 3 quarters · filed 2018-02-28 | $141.66M 10-K · filed 2018-02-28 |
| 2015-10-03 | $37.97M 10-Q · filed 2016-11-09 | $76.74M derived: sum of 2 quarters · filed 2016-11-09 | $106.53M 10-Q · filed 2016-11-09 | $139.16M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-07-04 | $38.77M 10-Q · filed 2016-08-09 | $68.56M 10-Q · filed 2016-08-09 | $101.20M derived: sum of 3 quarters · filed 2017-03-01 | $130.45M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-04-04 | $29.79M 10-Q · filed 2016-05-11 | $62.42M derived: sum of 2 quarters · filed 2017-03-01 | $91.68M derived: sum of 3 quarters · filed 2017-03-01 | $120.77M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-01-03 | $32.64M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $61.89M derived: sum of 2 quarters · filed 2017-03-01 | $90.98M derived: sum of 3 quarters · filed 2017-03-01 | $116.10M 10-K · filed 2017-03-01 |
| 2014-09-27 | $29.25M 10-Q · filed 2015-11-12 | $58.34M derived: sum of 2 quarters · filed 2015-11-12 | $83.46M 10-Q · filed 2015-11-12 | $112.47M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-06-28 | $29.09M 10-Q · filed 2015-08-12 | $54.21M 10-Q · filed 2015-08-12 | $83.21M derived: sum of 3 quarters · filed 2016-03-01 | $107.91M derived: sum of 4 quarters · filed 2016-03-01 |
| 2014-03-29 | $25.12M 10-Q · filed 2015-05-13 | $54.13M derived: sum of 2 quarters · filed 2016-03-01 | $78.82M derived: sum of 3 quarters · filed 2016-03-01 | $115.27M derived: sum of 4 quarters · filed 2016-03-01 |
| 2013-12-28 | $29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $53.70M derived: sum of 2 quarters · filed 2016-03-01 | $90.15M derived: sum of 3 quarters · filed 2016-03-01 | $116.71M 10-K · filed 2016-03-01 |
| 2013-09-28 | $24.69M 10-Q · filed 2014-11-06 | $61.15M derived: sum of 2 quarters · filed 2014-11-06 | $87.71M 10-Q · filed 2014-11-06 | $115.79M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-06-29 | $36.45M 10-Q · filed 2014-08-05 | $63.01M 10-Q · filed 2014-08-05 | $91.10M derived: sum of 3 quarters · filed 2015-03-17 | $115.18M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-03-30 | $26.56M 10-Q · filed 2014-05-07 | $54.64M derived: sum of 2 quarters · filed 2015-03-17 | $78.73M derived: sum of 3 quarters · filed 2015-03-17 | $103.88M derived: sum of 4 quarters · filed 2015-03-17 |
| 2012-12-29 | $28.08M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | $52.17M derived: sum of 2 quarters · filed 2015-03-17 | $77.32M derived: sum of 3 quarters · filed 2015-03-17 | $98.18M 10-K · filed 2015-03-17 |
| 2012-09-29 | $24.08M 10-Q · filed 2013-11-07 | $49.23M derived: sum of 2 quarters · filed 2013-11-07 | $70.10M 10-Q · filed 2013-11-07 | $90.20M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | $25.15M 10-Q · filed 2013-08-08 | $46.01M 10-Q · filed 2013-08-08 | $66.11M derived: sum of 3 quarters · filed 2014-03-13 | $84.89M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | $20.86M 10-Q · filed 2013-05-07 | $40.96M derived: sum of 2 quarters · filed 2014-03-13 | $59.74M derived: sum of 3 quarters · filed 2014-03-13 | $80.89M derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | $20.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $38.88M derived: sum of 2 quarters · filed 2014-03-13 | $60.03M derived: sum of 3 quarters · filed 2014-03-13 | $77.26M 10-K · filed 2014-03-13 |
| 2011-10-01 | $18.78M 10-Q · filed 2012-11-07 | $39.93M derived: sum of 2 quarters · filed 2012-11-07 | $57.16M 10-Q · filed 2012-11-07 | $75.28M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-07-02 | $21.15M 10-Q · filed 2012-08-08 | $38.38M 10-Q · filed 2012-08-08 | $56.51M derived: sum of 3 quarters · filed 2013-03-11 | $75.04M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-04-02 | $17.23M 10-Q · filed 2012-05-10 | $35.35M derived: sum of 2 quarters · filed 2013-03-11 | $53.89M derived: sum of 3 quarters · filed 2013-03-11 | $70.95M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-01-01 | $18.13M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $36.66M derived: sum of 2 quarters · filed 2013-03-11 | $53.73M derived: sum of 3 quarters · filed 2013-03-11 | $68.22M 10-K · filed 2013-03-11 |
| 2010-10-02 | $18.54M 10-Q · filed 2011-11-09 | $35.60M derived: sum of 2 quarters · filed 2011-11-09 | $50.09M 10-Q · filed 2011-11-09 | |
| 2010-07-03 | $17.06M 10-Q · filed 2011-08-10 | $31.55M 10-Q · filed 2011-08-10 | ||
| 2010-01-02 | $50.79M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |